English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The article presents the analysis of drug consumption by patients with acute leukemia in specialized health institutions of Ukraine. Patients with acute lymphocytic leukemia were prescribed almost twice drugs than patients with acute myeloid leukemia. It has been found that the names used for pathogenetic treatment of acute leukemia dominate in the structure of drug consumption. Thus, anticancer drugs are one of three leaders both by the frequency of medical prescriptions and by the amount of drug consumption. More than half of the resources are spent on the consumption of drugs, which are essential according to the requirements of the legal framework regulating issues of the medical process organization and pharmaceutical provision of patients with hematological malignancies. Taking into account the fact that the vast majority of patients belongs to socially vulnerable groups of the population the introduction of effective mechanisms to compensate the cost of expensive anticancer drugs is presented as the main direction of increasing the efficiency of pharmaceutical provision of patients with hematological malignancies.

The results of clinical and economic analysis of drug consumption in patients with acute lymphoid and myeloid leukemia in Ukraine